Calton & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,867
Closed -$957K 232
2023
Q1
$957K Buy
+11,867
New +$967K 0.44% 63
2022
Q1
Sell
-2,598
Closed -$268K 391
2021
Q4
$268K Sell
2,598
-1,515
-37% -$175K 0.07% 287
2021
Q3
$515K Sell
4,113
-671
-14% -$86.8K 0.11% 187
2021
Q2
$594K Buy
4,784
+28
+0.6% +$3.52K 0.11% 178
2021
Q1
$562K Buy
4,756
+220
+5% +$25.8K 0.11% 175
2020
Q4
$531K Sell
4,536
-148
-3% -$16.3K 0.09% 173
2020
Q3
$487K Buy
4,684
+610
+15% +$61.3K 0.1% 157
2020
Q2
$374K Buy
4,074
+256
+7% +$24.5K 0.08% 184
2020
Q1
$344K Sell
3,818
-596
-14% -$63.4K 0.09% 190
2019
Q4
$501K Buy
4,414
+879
+25% +$96.5K 0.1% 173
2019
Q3
$384K Sell
3,535
-728
-17% -$76K 0.09% 191
2019
Q2
$415K Buy
4,263
+867
+26% +$79.2K 0.12% 148
2019
Q1
$309K Sell
3,396
-821
-19% -$73.5K 0.09% 183
2018
Q4
$384K Buy
4,217
+112
+3% +$10.5K 0.14% 134
2018
Q3
$404K Sell
4,105
-1
-0% -$92 0.12% 152
2018
Q2
$373K Sell
4,106
-3,794
-48% -$317K 0.11% 149
2018
Q1
$634K Sell
7,900
-13,216
-63% -$1.09M 0.18% 118
2017
Q4
$1.8M Buy
+21,116
New +$1.69M 0.45% 33

Other funds holding MDT

Calton & Associates's MDT Position: Q2 2023 in Review

Calton & Associates sold out of Medtronic (MDT) in Q2 2023, closing a stake of 11,867 shares — an estimated $957K sold.

Calton & Associates first reported a position in MDT in Q4 2017 and held it in 18 quarters. The position peaked at $1.8M in Q4 2017. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Calton & Associates reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Calton & Associates sold 11,867 Medtronic shares in Q2 2023, an estimated $957K.
  • Calton & Associates first reported a position in Medtronic in Q4 2017 and held it in 18 quarters.
  • Calton & Associates's Medtronic position peaked at $1.8M in Q4 2017.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Calton & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.